TONELLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.186
AS - Asia 8.799
EU - Europa 8.079
SA - Sud America 1.371
Continente sconosciuto - Info sul continente non disponibili 366
AF - Africa 232
OC - Oceania 77
Totale 38.110
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.557
IT - Italia 3.520
SG - Singapore 2.770
CN - Cina 2.025
GB - Regno Unito 1.069
VN - Vietnam 1.007
BR - Brasile 987
HK - Hong Kong 886
DE - Germania 729
SE - Svezia 628
BD - Bangladesh 620
RU - Federazione Russa 365
FI - Finlandia 338
CA - Canada 335
FR - Francia 334
KR - Corea 252
IN - India 233
ID - Indonesia 221
NL - Olanda 194
AR - Argentina 144
TR - Turchia 138
JP - Giappone 137
UA - Ucraina 131
MX - Messico 129
BG - Bulgaria 87
ES - Italia 86
IE - Irlanda 83
IQ - Iraq 74
PL - Polonia 74
AU - Australia 70
CO - Colombia 70
ZA - Sudafrica 68
PK - Pakistan 63
LT - Lituania 59
RO - Romania 50
AT - Austria 48
CL - Cile 46
AE - Emirati Arabi Uniti 44
EC - Ecuador 44
BE - Belgio 42
CR - Costa Rica 37
CH - Svizzera 33
VE - Venezuela 32
EG - Egitto 30
MA - Marocco 30
TW - Taiwan 30
CZ - Repubblica Ceca 29
MY - Malesia 29
TH - Thailandia 27
JO - Giordania 25
SA - Arabia Saudita 24
JM - Giamaica 23
UZ - Uzbekistan 23
PH - Filippine 22
DZ - Algeria 21
KE - Kenya 20
SI - Slovenia 20
IR - Iran 19
PY - Paraguay 19
GR - Grecia 18
NP - Nepal 18
PR - Porto Rico 16
TN - Tunisia 16
AZ - Azerbaigian 15
DK - Danimarca 15
NO - Norvegia 15
PE - Perù 15
EE - Estonia 14
HU - Ungheria 14
IL - Israele 14
SV - El Salvador 14
PT - Portogallo 13
HN - Honduras 12
NI - Nicaragua 12
RS - Serbia 12
KZ - Kazakistan 11
SN - Senegal 11
DO - Repubblica Dominicana 10
TT - Trinidad e Tobago 10
GT - Guatemala 9
HR - Croazia 9
MD - Moldavia 9
OM - Oman 9
AL - Albania 7
GE - Georgia 7
KG - Kirghizistan 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
UY - Uruguay 7
BH - Bahrain 6
BY - Bielorussia 6
GA - Gabon 6
LB - Libano 6
PA - Panama 6
QA - Qatar 6
SY - Repubblica araba siriana 6
BO - Bolivia 5
ET - Etiopia 5
LI - Liechtenstein 5
MK - Macedonia 5
Totale 37.665
Salva come PNG Salva come JPEG
Città #
Ashburn 2.360
Singapore 1.786
Santa Clara 1.531
San Jose 1.289
Fairfield 1.279
Council Bluffs 962
Hong Kong 853
Chandler 840
Woodbridge 599
Hefei 580
Houston 522
Seattle 483
Cambridge 409
Southend 399
New York 386
Beijing 384
Wilmington 371
London 362
Nyköping 349
Los Angeles 335
Ho Chi Minh City 325
Milan 322
Ann Arbor 307
Modena 278
Chicago 246
Helsinki 242
Seoul 232
Hanoi 228
San Diego 213
Rome 204
Bologna 201
Jakarta 188
The Dalles 173
Dallas 163
Dearborn 160
Munich 158
Jacksonville 131
Moscow 111
Buffalo 109
São Paulo 107
Shanghai 106
Lauterbourg 104
Tokyo 103
Princeton 96
Toronto 91
Orem 84
Sofia 84
Atlanta 81
Boardman 78
Redwood City 68
Naples 66
Dublin 64
Salt Lake City 63
Grafing 62
Parma 62
Frankfurt am Main 60
Montreal 58
Mexico City 55
Warsaw 55
Turin 54
Phoenix 49
Chennai 47
Columbus 47
Elk Grove Village 47
Nuremberg 47
Mumbai 46
Bremen 45
Da Nang 44
Denver 44
Verona 44
Brooklyn 43
Eugene 43
Lappeenranta 42
Florence 41
Poplar 41
Haiphong 39
Reggio Emilia 39
Miami 38
North York 38
Sydney 36
Rio de Janeiro 35
Hangzhou 33
Johannesburg 33
Washington 33
Ankara 32
Brussels 32
Guangzhou 32
Hillsboro 32
Turku 32
Tampa 31
Kent 30
Baghdad 29
Boston 28
Izmir 28
Redondo Beach 28
Stockholm 28
Amsterdam 27
Des Moines 27
Palermo 27
San José 27
Totale 23.135
Salva come PNG Salva come JPEG
Nome #
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 560
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 536
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 484
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 459
Acute exacerbation of Idiopathic Pulmonary Fibrosis: lessons learned from the Acute Respiratory Distress Syndrome 451
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 449
Insufficienza respiratoria acuta e cronica (cap.21). 431
Delirium and risk factors in patients undergoing non-invasive ventilation for de novo acute respiratory failure: an observational multicenter trial. 428
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 426
Acute severe asthma: management and treatment. 419
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 414
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 406
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 396
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 389
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 389
Incidence, etiology and clinico-pathologic features of endobronchial benign lesions: 10 consecutive years rerospective study 385
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 384
An uncommon cause of hemoptysis: aortobronchial fistula. 381
Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment 364
The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis 361
When Acute Respiratory Distress Syndrome is not ARDS 360
Prevalence and outcome of diaphragmatic dysfunction assessed by ultrasound technology during acute exacerbation of chronic obstructive pulmonary disease: a pilot study. 360
Spontaneous breathing and evolving phenotypes of lung damage in patients with COVID-19. 357
Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE). 354
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy 353
Hypokalemia in Patients with COVID-19 352
Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure 351
Optimization of intranasal bleomycin dose for effective pulmonary fibrosis induction in mice with minimal animal distress. 350
An uncommon cause of pneumonia: The golden diagnosis 348
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 348
Molecular Mechanisms and Physiological Changes behind Benign Tracheal and Subglottic Stenosis in Adults 347
Ventilatory support and mechanical properties of the fibrotic lung acting as a “squishy ball” 344
Serial Ultrasound Assessment of Diaphragmatic Function and Clinical Outcome in Patients with Amyotrophic Lateral Sclerosis. 343
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 342
Pulmonary stretch and lung mechanotransduction: Implications for progression in the fibrotic lung 338
Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. 338
Prevalence and development of chronic critical illness in acute patients admitted to a respiratory intensive care setting 337
Use of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Case Study 336
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 336
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 328
Early inspiratory effort assessment by esophageal manometry early predicts noninvasive ventilation outcome in de novo respiratory failure: a pilot study. 327
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 326
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 325
Breakthroughs in internal and respiratory medicine 323
Etiology and Level of Lung Derangement Do Not Affect the Beneficial Effect of Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases 321
Inspiratory effort and respiratory mechanics in spontaneously breathing patients with acute exacerbation of idiopathic pulmonary fibrosis: a retrospective matched control study. 319
Novel drug targets for idiopathic pulmonary fibrosis 318
Respiratory mechanics and diaphragmatic dysfunction in COPD patients who failed non-invasive mechanical ventilation 318
Peritoneal dialysis in the time of coronavirus disease 2019 318
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 303
Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study 297
The Effect Of Bronchodilators On Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis 295
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 294
Proprietà meccaniche e comportamento elastico del polmone affetto da fibrosi con pattern "polmonite interstiziale tipica" in corso di ventilazione meccanica: sviluppo e significato clinico della teoria del polmone "squishy ball" 294
COPD exacerbation and diaphragmatic dysfunction: Conditions with mutual influence influencing outcomes? - Reply. 293
Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis. 292
High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial 291
Ultrasound assessed Diaphragm Impairment is a Predictor of Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease undergoing Non-Invasive Ventilation. 288
Effect of high flow nasal oxygen on inspiratory effort of patients with acute hypoxic respiratory failure and do not intubate order. 284
COVIDGuide una app per il triage e l'autovalutazione della COVID-19. 283
Looking for a Chronic Care Model in COPD patients 280
Real-life comparison of Pirfenidone and Nintedanib in patients with Idiopathic Pulmonary Fibrosis: a 24-month assessment. 280
Atypical diagnosis for typical lung carcinoid 277
Never Give Up: lesson learned from a severe COVID-19 patient. 275
The encaged lung: rapidly progressive idiopathic pleurisy. 274
Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure 274
Endobronchial valve positioning for alveolar-pleural fistula following ICU management of severe COVID-19 pneumonia. 269
STenting veRsus balloOn dilatation in patients with tracheal BEnign stenosis – the STROBE trial. 269
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 267
Inspiratory effort and lung mechanics in spontaneously breathing patients with acute respiratory failure due to COVID-19. A matched control study. 265
Biological effects of COVID-19 on lung cancer: can we drive our decisions? 260
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 258
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 251
Endoscopic Bronchopleural Fistula Repair Using Autologous Fat Graft 249
Dissecting the role of mesenchymal stem cells in idiopathic pulmonary fibrosis: cause or solution? 248
Changes in clinical characteristics and outcomes of patients admitted to inpatient cardiac rehabilitation 247
Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. 246
Janus-faced amiodarone-induced pneumopathy 245
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. 245
The association of procalcitonin and C- reactive protein with bacterial infections acquired during ICU stay in COVID-19 critically ill patients. 240
Response Letter to Tuffet S, et al. and to Michard F, et al. 239
Assessing respiratory drive and inspiratory effort in critically ill patients at the bedside 237
An Italian sacrifice to COVID-19 epidemic. 236
Impaired function in the complex patient with COPD: a matter to be considered 235
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 235
Monitoring and modulation of respiratory drive in patients with acute hypoxemic respiratory failure in spontaneous breathing 233
Vanishing lung emphysema during chemotherapy for malignant pleural mesothelioma. 233
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases. 232
Physiological effects of lung protective ventilation in patients with lung fibrosis and usual interstitial pneumonia pattern versus primary ARDS: a matched-control study. 231
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 228
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 227
Accuracy of nasal pressure swing to predict failure of high flow nasal oxygen in patients with acute hypoxemic respiratory failure 226
An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy 226
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 224
Development of clinical tools to estimate the breathing effort during high-flow oxygen therapy: A multicenter cohort study 224
Correction: Endobronchial valve positioning for alveolar-pleural fistula following ICU management complicating COVID-19 pneumonia (BMC Pulmonary Medicine, (2021), 21, 1, (307), 10.1186/s12890-021-01653-w) 222
The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance. 221
Unusual effectiveness of systemic steroids in Whipple disease. 220
Extensive tracheal injuries: a reasoned multi-step approach to guarantee mechanical ventilatory support developed during COVID-19 pandemic. 220
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: a multicentre regional cohort study. 219
Totale 31.330
Salva come PNG Salva come JPEG
Categoria #
all - tutte 151.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.636
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.344 0 0 0 122 160 201 195 175 486 220 459 326
2022/20232.874 346 363 250 281 279 361 94 274 334 57 124 111
2023/20242.367 68 110 182 223 330 243 278 242 102 120 189 280
2024/20256.252 178 123 143 455 1.077 919 515 410 684 318 576 854
2025/202613.611 971 566 999 1.576 1.848 778 1.561 683 1.269 1.331 1.170 859
2026/20274.695 563 1.857 1.039 1.236 0 0 0 0 0 0 0 0
Totale 38.110